Floatz logo

Allogeneic Cd34+-Enriched And Cd45Ra-Depleted Pbscs

Immune Deficiency Disease

Federal Research Institute of Pediatric Hematology, Oncology and ImmunologyCell therapyPhase 1/2Dormant
CCC
52/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
37/ 100
Competitive Position
95/ 100

Competitive context

9 Active assets in the Immune Deficiency Disease cohort.

Asset / SponsorPhaseRating
Busulphan
University of California, San Francisco
Phase 2BB
Evomela
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Phase 2BB
Thiotepa
University of California, San Francisco
Phase 2BB
Fludarabine
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Phase 2BB
HUMAN IMMUNOGLOBULINS
Grifols Therapeutics LLC
Phase 3B

View all 23 →

Same molecule, other indications

Allogeneic Cd34+-Enriched And Cd45Ra-Depleted Pbscs is also rated in:

acute lymphoblastic leukemiaDormant
BBB
Indicative ·
74 / 100
View asset →
Acute Myelogenous LeukemiaDormant
BB
Indicative ·
70 / 100
View asset →
Myelodysplastic SyndromesDormant
BB
Indicative ·
68 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →